Fundraising Fox
BioLamina
Stockholm, SE · Founded 2009 · 117 employees on LinkedIn · 2 known investors
Find your way into BioLamina
Sign up to see every warm intro you have to BioLamina
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioLamina team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.
Founders & leadership
BioLamina was founded in 2009 by Kristian Tryggvason and Karl Tryggvason.
Investors · 2
How we know: Lauxera Capital Partners's portfolio page · funding news · Not right? Tell us
How we know: funding news · biostock.se · Not right? Tell us
In the news
Frequently asked questions
- What does BioLamina do?
- BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.
- Who founded BioLamina?
- BioLamina was founded by Kristian Tryggvason, Karl Tryggvason in 2009.
- Who are BioLamina's investors?
- BioLamina's investors include Lauxera Capital Partners, European Investment Bank.
- Where is BioLamina headquartered?
- BioLamina is headquartered in Stockholm, SE.